Furthermore, the number of cholinergic neurons was dramatically reduced in AD (Yan et al., 2018), while the application of NGF in AD mice prevented cholinergic deficit, β-amyloid accumulation, and memory loss (Eyjolfsdottir et al., 2016; Yan et al., 2018). This evidence concerns the gene NGF and Alzheimer disease.